These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 6738754)
1. Differences in the blast cells sensitivity to cytostatic drugs in various acute leukemia types and their clinical implications. Kuliszkiewicz-Janus M Neoplasma; 1984; 31(3):291-8. PubMed ID: 6738754 [TBL] [Abstract][Full Text] [Related]
2. Cytoenzymochemical changes in acute leukemia cells under cytostatic treatment. Rădulescu E Morphol Embryol (Bucur); 1984; 30(3):205-10. PubMed ID: 6239098 [TBL] [Abstract][Full Text] [Related]
3. Examination of leukaemic blasts sensitivity to cytostatic drugs using two short-term laboratory methods. Kotlarek-Haus S; Grzybek-Hryncewicz K; Kuliszkiewicz-Janus M; Kuliczkowski K; Biernacka I; Brzuchowska W; Mulczyk A Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):664-70. PubMed ID: 6172331 [TBL] [Abstract][Full Text] [Related]
5. [Determination of the sensitivity of leukemic blasts to cytostatic agents by means of an isotope method]. Kuliszkiewicz-Janus M Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):213-7. PubMed ID: 6168529 [No Abstract] [Full Text] [Related]
6. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia. Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461 [TBL] [Abstract][Full Text] [Related]
7. [The trials of determination of acute leukemia blasts sensitivity against cytostatics (author's transl)]. Grazybek-Hryncewicz K; Biernacka I; Brzuchowska W; Kuliczkowski K; Luczkiewicz-Mulczykowa A; Kotlarek-Haus S Przegl Lek; 1981; 38(2):289-94. PubMed ID: 6941335 [No Abstract] [Full Text] [Related]
8. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man. Killmann SA Schweiz Med Wochenschr; 1974 Feb; 104(8):278-84. PubMed ID: 4814680 [No Abstract] [Full Text] [Related]
9. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia. Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227 [TBL] [Abstract][Full Text] [Related]
10. Micronucleus test applied in patients with acute leukemia, before and at different intervals during the cytostatic treatment. Mihalache D; Stefănescu DT; Motoiu I; Constantiniu L; Costache A; Dumitrescu A Morphol Embryol (Bucur); 1989; 35(3):209-15. PubMed ID: 2530446 [TBL] [Abstract][Full Text] [Related]
11. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia]. Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381 [TBL] [Abstract][Full Text] [Related]
12. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis. Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208 [TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644 [TBL] [Abstract][Full Text] [Related]
14. [Kinetic effect of cytostatic drugs on the generation cycle of human leukaemic blast cells in vivo. A review]. Ernst P Ugeskr Laeger; 1974 Mar; 136(13):695-703. PubMed ID: 4522768 [No Abstract] [Full Text] [Related]
15. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia]. Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050 [TBL] [Abstract][Full Text] [Related]
16. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis. Shumak KH; Baker MA; Taub RN; Coleman MS Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of isolated mononuclear cells from patients with acute myeloid leukemia affects cellular accumulation and efflux of daunorubicin. Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C Haematologica; 2000 Feb; 85(2):124-32. PubMed ID: 10681718 [TBL] [Abstract][Full Text] [Related]
18. [Plasma fibronectin in acute leukemia. Effects of the cytostatic therapy on plasma fibronectin level]. Anders O; Backhaus M; Mielke F; Emmrich J; Konrad H Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(3):348-58. PubMed ID: 2444508 [TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia. Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929 [TBL] [Abstract][Full Text] [Related]
20. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]